Cubist Systematic Strategies »

Zenas Biopharma shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2024-09-30 $64k 3.8k 16.92

More positions owned by Cubist Systematic Strategies

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
Microsoft Corporation (MSFT)
Super Micro Computer Call Option
General Motors Company (GM)
Spotify Technology S A SHS (SPOT)
Meta Platforms Cl A (META)
Micron Technology Call Option (MU)
Arm Holdings Sponsored Ads Call Option (ARM)
Intel Corporation Call Option (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Snowflake Cl A (SNOW)
Tesla Motors Call Option (TSLA)

View all positions for Cubist Systematic Strategies

Top funds holding Zenas Biopharma

NEA Management Company
Fairmount Funds Management
NVP Associates
Deerfield Management Company
Federated Investors
Novo A/S
Perceptive Advisors
Pivotal bioVenture Partners Investment Advisor
T. Rowe Price Associates
Arrowpoint Asset Management
Monashee Investment Management
Citadel Advisors
Standard Life Aberdeen
Point72 Asset Management
Soros Fund Management

View all funds holding Zenas Biopharma